CMG-SDIC Capital and Tigermed Lead USD100m Series D for Chinese Drug Developer Adlai Nortye
Source(s): AVCJ
CMG-SDIC Capital Management and Hong Kong-based contract research organization Tigermed led a USD100m Series D for China-based drug developer Adlai Nortye, with participation from Legend Star, Guolian Fund, Triwise Capital, ATCG and Chinese social video platform Tian Ge Interactive Holdings. Read more